8 Followers on Owler

Visterra

develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases... Read more
OverviewCompetitorsFundingNews & Insights

Visterra

develops and commercializes antibody therapeutics for the treatment of pandemic influenza and chronic kidney diseases... Read more
Visterra President & CEO: Brian J. G. Pereira

President & CEO

Brian J. G. Pereira

CEO Approval Rating

90/100

2007

PrivateAcquired by Otsuka Holdings Co., Ltd.

Pharmaceuticals & Biotechnology
Biotechnology
2834 NAICS listing

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$144.5M

News

Partnership
Dec 16, 2024
FinanzNachrichten
Scailyte and Visterra Partner to Advance Autoimmune Disease Research

Visterra Competitors

1Immune Design
2Arsanis
3Chimerix
4CytoAgents
5Oncoinvent
6Kite Pharma
7Alebund
8Inovio
9Pliant
10Aridis
Unlock 11 + competitors

Trending Companies